Founded in 2021, biotech start-up Ignota Labs wants to give promising but flawed drugs a new chance for market approval.

The Wild clinched a berth into the 2025 Stanley Cup Playoffs by tallying a tying goal in the final 30 seconds of regulation ...

AstraZeneca, Tempus and Pathos AI have signed a multi-year agreement to develop a large-scale multimodal deep learning model designed to accelerate cancer drug discovery. The companies say the ...

AstraZeneca recently reported a 1.9% decline in its share price over the last week. This movement coincides with the broader market's downturn, which saw a 1.1% drop amid ongoing concerns about ...

April 22 (Reuters) - AstraZeneca (AZN.L), opens new tab has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical Research and Manufacturers of America ...

AstraZeneca has started work with tech companies Tempus and Pathos AI on a project that aims to generate a wide-ranging and comprehensive generative artificial intelligence model for oncology.

AstraZeneca has rejoined PhRMA as it expands its “presence in the United States with significant investments in research, development and manufacturing,” Pascal Soriot, AZ’s CEO, said in a ...

LONDON, April 23 (Reuters) - AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe has stepped up its defence spending it now must do the same and invest more ...

A cancer drug from partners AstraZeneca and Daiichi Sankyo currently approved as a second-line or later treatment for metastatic breast cancer has interim clinical data showing it helped patients ...

The CEO of FTSE 100 giant Astrazeneca has spoken out. (Photo by Christopher Furlong/Getty Images) Europe is putting its “ability to protect the health of its own people at risk” by not ...

Jordan has imposed a sweeping ban on the Muslim Brotherhood, the country’s most vocal opposition group, after members of the group were found to be linked to a sabotage plot, Minister of the ...